Skip to main content
. Author manuscript; available in PMC: 2018 Apr 13.
Published in final edited form as: Nature. 2016 Nov 7;539(7629):384–389. doi: 10.1038/nature20134

Extended Data Figure 7. Genome-edited human HSPCs in the bone marrow of NSG mice at Week 16 post transplantation.

Extended Data Figure 7

Representative FACS plots from the analysis of NSG mice from the (A) Mock or (B) RNP+AAV experimental group at Week 16 post transplantation. Mice were sacrificed and bone marrow was harvested, PBMCs were isolated via Ficoll density gradient, after which human CD34+ cells were enriched by magnetic-activated cell sorting (MACS), and finally cells were stained with antiCD34, antiCD38, and antiCD10 antibodies to identify human GFP+ cells in the CD34+/CD10- and CD34+/CD10-/CD38- populations (note that CD10 was included as a negative discriminator for immature B cells) (C) Collective data from the analysis of GFP+ cells in the human CD34+/CD10- population from the RNP+AAV (N=11) and RNP+AAV GFPhigh (N=6) experimental groups. For the RNP+AAV GFPhigh group, cells from all six mice were pooled before analysis and thus, no error bar is available. Error bar on RNP group represents S.E.M.